top of page

At the 6th Annual Meeting of the Japanese Society of Foot Care and Podiatric Medicine, we presented on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemia (CLT...

  • Feb 28
  • 1 min read


At the 6th Annual Scientific Meeting of the Japanese Society of Foot Care and Podiatric Medicine, held from February 27th to 28th , a presentation was given on comprehensive angiogenesis therapy for severe chronic lower limb ischemia (CLTI) using ICS-001, which is currently undergoing clinical trials.

As a sponsored seminar co-hosted by our company, under the moderation of Dr. Atsuhiko Kawamoto of the Kobe Biomedical Innovation Cluster (TRI), presentations were given by Dr. Osamu Iida, Chairman of the Clinical Trial, Dr. Masahide Furukawa of Oita Oka Hospital, Dr. Yasuyuki Fujita of the Kobe Biomedical Innovation Cluster (TRI), and our CEO, Kenichi Yamahara, all of whom are cooperating in this clinical trial.


 
 
 

Comments


Latest Articles
archive
Cellfold Co., Ltd.

© 2025 by CellFold, Inc.

bottom of page